From resistant hypertension to renal denervation: an emerging therapeutic approach in light of new international guidelines
{{output}}
Background: Resistant hypertension (RH) remains a major therapeutic challenge, affecting 12-18 % of treated hypertensive patients and associated with increased cardiovascular risk. Renal denervation (RDN) has emerged as a promisi... ...
